Unrelated cord blood transplantation in a child with very severe aplastic anemia
-
- YASUI Naoko
- Department of Hematology/Oncology, Saitama Children's Medical Center
-
- KOH Katsuyoshi
- Department of Hematology/Oncology, Saitama Children's Medical Center
-
- PARK Myoung-Ja
- Department of Hematology/Oncology, Gunma Children's Medical Center
-
- KATO Motohiro
- Department of Hematology/Oncology, Saitama Children's Medical Center
-
- MORI Makiko
- Department of Hematology/Oncology, Saitama Children's Medical Center
-
- AKIYAMA Kosuke
- Department of Hematology/Oncology, Saitama Children's Medical Center
-
- SEKI Masafumi
- Department of Hematology/Oncology, Saitama Children's Medical Center
-
- TAKAHASHI Hiroyoshi
- Department of Hematology/Oncology, Saitama Children's Medical Center
-
- HANADA Ryoji
- Department of Hematology/Oncology, Saitama Children's Medical Center
Bibliographic Information
- Other Title
-
- 非血縁者間臍帯血移植を施行した小児最重症再生不良性貧血
- 症例報告 非血縁者間臍帯血移植を施行した小児最重症再生不良性貧血
- ショウレイ ホウコク ヒケツエンシャ カン サイタイケツ イショク オ シコウ シタ ショウニ サイジュウショウ サイセイ フリョウセイ ヒンケツ
Search this article
Description
Recently, bone marrow transplantation from an unrelated donor has been recommended as an option for the treatment of very severe aplastic anemia (vSAA) refractory to immunosuppressive therapy (IST) in the absence of a human leukocyte antigen-matched related donor (MRD). For SAA patients with complications such as bacterial infections, prompt transplantation using either a mismatched related donor or cord blood (CB) becomes necessary. However, the former option is associated with graft-versus-host disease, whereas the latter option is associated with a more significant risk of graft failure. We report a patient with vSAA refractory to IST that was repeatedly complicated by bacterial infection. An MRD was unavailable for this patient, so we decided on emergent transplantation and successfully performed CB transplantation (CBT) using a low-dose TBI conditioning regimen. Although it may be necessary to examine more clinical cases in the future, a conditioning regimen such as that involving low-dose TBI may decrease the risk of graft failure, and CBT may become a treatment option for vSAA in the absence of a suitable donor.
Journal
-
- Rinsho Ketsueki
-
Rinsho Ketsueki 53 (12), 1997-2002, 2012
The Japanese Society of Hematology
- Tweet
Details 詳細情報について
-
- CRID
- 1390282680013808768
-
- NII Article ID
- 10031147806
-
- NII Book ID
- AN00252940
-
- COI
- 1:STN:280:DC%2BC3s3psVKltg%3D%3D
-
- ISSN
- 18820824
- 04851439
-
- NDL BIB ID
- 024191082
-
- PubMed
- 23318965
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed